PolyPeptide Group Dividend Coverage
Dividend Coverage Ratio of PolyPeptide Group (PPGN.SW) as of Aug 12, 2026.
Get this data via API
Financial Data API
Dividend Coverage
0.00
Last updated:
Dividend Coverage Ratio of PolyPeptide Group is 2026 0.00 . Dividend Coverage Ratio of PolyPeptide Group was 2025 0.00 . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API
PolyPeptide Group Stock analysis
What does PolyPeptide Group do? PolyPeptide Group AG is a leading company in peptide chemistry and offers customized peptide solutions for a variety of applications to its customers. The company was founded in 1994 and is headquartered in Zurich, Switzerland. PolyPeptide has branches in seven countries and operates worldwide in over 80 countries.
The company works with customers from various industries, including the pharmaceutical industry, biotechnology, diagnostics, as well as cosmetics and food industries. With many years of experience, a deep understanding of peptide chemistry, and state-of-the-art technologies, PolyPeptide is able to offer its customers first-class and tailor-made peptide solutions.
PolyPeptide is divided into three divisions: Generics, Innovative Peptides, and Peptide Manufacturing. In the Generics division, the company offers a wide range of generic peptides that can be used for various applications. These peptides are manufactured to the highest quality standards and are cost-effective alternatives to expensive proprietary peptides.
The Innovative Peptides division offers customized peptide solutions for specific applications. These peptides are developed in close collaboration with customers and can be used for the treatment of cancer, autoimmune diseases, diabetes, and other conditions.
The third division, Peptide Manufacturing, specializes in the production of peptides for clinical studies and commercial production. PolyPeptide has modern production facilities and strict quality controls to ensure that the peptides meet the highest quality standards.
PolyPeptide's business model is based on close collaboration with customers and partners to develop tailor-made peptide solutions. The company works closely with its customers to understand their requirements and develop suitable peptides for their specific applications. PolyPeptide has an experienced team of scientists and technicians specialized in peptide synthesis and continuously focuses on the latest knowledge in peptide chemistry.
PolyPeptide offers a wide range of products, including generic peptides for research purposes, customized peptides for specific applications, peptides for clinical studies, and for commercial production. The company has a wealth of experience in peptide chemistry and has acquired numerous patents for its technologies and methods.
In summary, PolyPeptide Group AG is a leading company in peptide chemistry. The company offers customized peptide solutions for a variety of applications and has extensive experience in manufacturing peptides for the pharmaceutical industry, biotechnology, diagnostics, cosmetics, and food industry. Through its close collaboration with customers and state-of-the-art technologies, PolyPeptide is able to offer its customers first-class and cost-effective peptide solutions, solidifying its position as a leader in peptide chemistry. PolyPeptide Group is one of the most popular companies on Eulerpool.
Frequently Asked Questions about PolyPeptide Group stock
On Eulerpool you can find the complete historical development of Dividend Coverage Ratio PolyPeptide Group since 2006 – with annual values, charts, and detailed analysis.
The dividend coverage ratio measures how many times dividends can be covered by net income. Higher coverage suggests more sustainable dividend payments.
Dividend Coverage Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Coverage Ratio's PolyPeptide Group historically and in real time.
Access this data via the Eulerpool API
Dividend — PolyPeptide Group
All Key Metrics — PolyPeptide Group
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth